Literature DB >> 16528489

Biofeedback therapy for rectal intussusception.

Y H Hwang1, B Person, J S Choi, Y S Nam, J J Singh, E G Weiss, J J Nogueras, S D Wexner.   

Abstract

BACKGROUND: Surgery for isolated internal rectal intussusception is controversial due to high morbidity. Therefore, there is interest in other forms of treatment that are safe and effective. The aim of this study was to determine outcome and identify predictors for success of biofeedback therapy in patients with rectal intussusception.
METHODS: We retrospectively evaluated the results of electromyography (EMG)-based biofeedback in 34 patients with rectal intussusception without any other major pelvic floor or colonic physiologic disorder.
RESULTS: A total of 34 patients (7 men) had undergone at least 2 biofeedback sessions. The patients had a mean age of 68.5 years (SD=11.4 years). In the 27 patients with constipation, the frequency of weekly spontaneous bowel movements (mean+/-SD) was 2.0+/-6.8 before and 4.1+/-4.6 after biofeedback (p<0.05). The frequency of weekly assisted bowel movements decreased from 3.8+/-3.5 before to 1.5+/-2.2 after therapy (p<0.005). The number of patients who experienced incomplete evacuation decreased from 17 (63%) to 9 (33%) (p<0.05). Thirty-three percent of patients had complete resolution of the symptoms, 19% had partial improvement, and 48% had no improvement. Patients with constipation lasting less than nine years had a 78% success rate vs. 13% in patients who were constipated more than 9 years (p<0.01). In seven patients with incontinence, the frequency of daily incontinence episodes decreased from 1.0+/-0.7 before to 0.07+/-0.06 after biofeedback (p<0.05). The fecal incontinence score decreased from 13.1+/-4.2 before to 4.6+/-3.6 after treatment (p<0.005). Two patients (29%) were completely continent following biofeedback, 2 had partial improvement, and 3 (43%) had no significant improvement. There was no mortality in either group.
CONCLUSIONS: Biofeedback is a safe and effective treatment option for constipation and fecal incontinence due to rectal intussusception in patients who are willing to complete the course of treatment. Long-standing constipation is less effectively cured by biofeedback.

Entities:  

Mesh:

Year:  2006        PMID: 16528489     DOI: 10.1007/s10151-006-0244-7

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  8 in total

1.  Stapled transanal resection of the rectum (STARR) for the obstructed defaecation syndrome.

Authors:  Ridzuan Farouk; R Bhardwaj; R K S Phillips
Journal:  Ann R Coll Surg Engl       Date:  2009-05       Impact factor: 1.891

2.  Complications and reinterventions after surgery for obstructed defecation.

Authors:  Mario Pescatori; Giovanni Milito; Marina Fiorino; Federica Cadeddu
Journal:  Int J Colorectal Dis       Date:  2009-01-23       Impact factor: 2.571

3.  Functional disorders: rectoanal intussusception.

Authors:  Eric G Weiss; Elisabeth C McLemore
Journal:  Clin Colon Rectal Surg       Date:  2008-05

Review 4.  Management of obstructed defecation.

Authors:  Vlasta Podzemny; Lorenzo Carlo Pescatori; Mario Pescatori
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 5.  Functional Disorders: Rectoanal Intussusception.

Authors:  Kristen Blaker; Joselin L Anandam
Journal:  Clin Colon Rectal Surg       Date:  2017-02

6.  Management of patients with rectal prolapse: the 2017 Dutch guidelines.

Authors:  E M van der Schans; T J C Paulides; N A Wijffels; E C J Consten
Journal:  Tech Coloproctol       Date:  2018-08-11       Impact factor: 3.781

7.  Constipation and obstructed defecation.

Authors:  Scott R Steele; Anders Mellgren
Journal:  Clin Colon Rectal Surg       Date:  2007-05

8.  Referral for anorectal function evaluation is indicated in 65% and beneficial in 92% of patients.

Authors:  Maria M Szojda; Erik Tanis; Chris J J Mulder; Richelle J F Felt-Bersma
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.